
Sarepta soars as revenue beats estimates on Elevidys milestone
Flock Safety holds a ribbon cutting for their office in Boston's Seaport on July 22.
Danielle Parhizkaran/Globe Staff
Flock Safety said Thursday it will add artificial intelligence to its surveillance products used by US police departments, an update the company said will help make society safer and that privacy advocates have called 'abominable.' The sometimes controversial $7.5 billion Atlanta-based startup, which opened a second office last month in Boston, is best known for providing customers with automated license plate readers they can use to track vehicles nationwide. The new tool, Flock Intelligence, lets users investigate crimes using natural language to surface relevant records, images, and other data troves. The new, more powerful software offers a few dozen relevant images in a few seconds rather than requiring a manual review of thousands. The software also automatically pulls data, including footage collected in real-time from relevant Flock camera locations the moment a 911 call begins. Infusing AI into the software is designed to automate investigative work, narrowing thousands of leads to dozens 'instantly,' said Flock chief executive officer Garrett Langley. — BLOOMBERG NEWS
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
FINANCE
Advertisement
Trump opens the door for private equity and crypto as 401(k) retirement plan options
Advertisement
Millions of Americans saving for retirement through 401(k) accounts could have the option of putting their money in higher-risk private equity and cryptocurrency investments, according to an executive order signed Thursday by President Trump that could give those financial players long-sought access to a pool of funds worth trillions. There is no immediate change in how people invest part of their work earnings. Federal agencies would need to rewrite regulations to allow the expanded choices, and that would take months or more to complete. But once done, employers could offer a broader array of mutual funds and investments to workers, according to the White House. The president's order directs the Labor Department and other agencies to redefine what would be considered a qualified asset under 401(k) retirement rules. — ASSOCIATED PRESS
MERGER
Paramount and Skydance close their merger, kicking off reign of new entertainment giant
Paramount Pictures Studio will be part of the conglomerate.
Apu Gomes/Getty
Skydance and Paramount officially closed their $8 billion merger on Thursday — kicking off the reign of a new entertainment giant after a contentious, year-long endeavor to get the transaction over the finish line. The new company — which will trade under the 'PSKY' ticker on Wall Street — brings Paramount's legacy Hollywood footprint, major TV networks CBS and MTV, streaming services, and more under the roof of a new power player: billionaire Skydance founder David Ellison. The merger's close came just two weeks after it received regulatory approval from the Trump administration. While now a done deal, the path toward that approval was far from smooth. Months of scrutiny and turmoil surrounded the transaction — particularly amid President Trump's legal battle with '60 Minutes,' the crown jewel of Paramount-owned broadcast network CBS. With the specter of the Trump administration potentially blocking the hard-fought deal with Skydance, Paramount agreed to pay a $16 million settlement to the president in early July. — ASSOCIATED PRESS
Advertisement
CHIPMAKER
Intel's stock tumbles after Trump says its CEO must resign
Intel CEO Lip-Bu Tan has been urged to divest investments in Chinese companies.
Chiang Ying-ying/Associated Press
Shares of Intel slumped Thursday after President Trump said in a social media post that the chipmaker's CEO needs to resign. 'The CEO of Intel is highly CONFLICTED and must resign, immediately,' Trump posted on Truth Social. 'There is no other solution to this problem. Thank you for your attention to this problem!' Trump made the post after Senator Tom Cotton sent a letter to Intel chairman Frank Yeary expressing concern over CEO Lip-Bu Tan's investments and ties to semiconductor firms that are reportedly linked to the Chinese Communist Party and the People's Liberation Army, and asked the board whether Tan had divested his interests in these companies to eliminate any conflicts of interest. Intel did not immediately respond to a request for comment, so it is not immediately clear if Tan, who took over as Intel's CEO in March, has divested his interests in the companies. — ASSOCIATED PRESS
MEDIA
Closure of Midwest-based newspaper chain leaves dozens of communities without a news source
Dozens of communities in the Midwest and West learned Thursday they had lost their newspapers after an Illinois-based publisher announced it would abruptly close because of financial problems. News Media Corp., which owns local newspapers across five states, said it will close 14 operations in Wyoming, seven in Illinois, five in Arizona, four in South Dakota, and one in Nebraska. Touting itself as 'the voice of small town America,' NMC's closure affects longtime newspapers that were often the primary source of news in numerous small towns, worsening the problem of news deserts in rural areas. The closure follows a decades-long pattern of financial challenges for local newspapers — the US has lost over one-third of its print newspapers and two-thirds of its newspaper journalists since 2004 as the news media has struggled to adopt to a changing readership and revenue landscape, according to the Medill Local News Initiative at Northwestern University. — ASSOCIATED PRESS
Advertisement
HEALTH CARE
GLP-1 weight-loss pills are coming. So are doubts about their potency.
The Eli Lilly headquarters in Indianapolis.
AJ Mast/Photographer: AJ Mast/Bloomberg
Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will patients embrace a more convenient alternative to injecting themselves, even if it means losing less weight? Eli Lilly said Thursday it will seek regulatory approval for its experimental weight-loss pill by the end of the year, announcing results from its latest clinical trial that, while positive, did not appear to be as potent as injectable anti-obesity medications. The pharmaceutical giant said clinical trial participants taking the highest dose of its once-a-day pill lost an average of 12.4 percent of their body weight, compared with a placebo group that lost less than 1 percent, over 72 weeks. That fell short of the weight loss achieved by participants injecting semaglutide, the active ingredient in Ozempic and Wegovy, in an earlier clinical trial. — WASHINGTON POST
Trump orders federal regulators to probe alleged bank discrimination against conservatives
President Trump has accused JPMorgan and Bank of America of debanking him and his companies in the past, something both banks have denied.
HARUKA SAKAGUCHI/NYT
President Trump on Thursday signed an executive order mandating a probe into whether banks have discriminated against conservatives and certain industries including gun manufacturers and cryptocurrency companies, invoking the vast powers to go after entities that the Republican president alleges have discriminated against him and his allies. The executive order deals with an issue known as 'debanking,' which is when banks close accounts of individuals or declines to go into business with certain industries. Trump has accused JPMorgan and Bank of America of debanking him and his companies in the past, something both banks have denied. Trump ordered federal bank regulators to make sure banks do not discriminate against individuals or companies for their political or religious beliefs. He also ordered bank regulators to probe when banks may have allegedly discriminated and refer the cases to the Department of Justice. The move could open banks to potential civil or criminal investigations, fines, or punishments. — ASSOCIATED PRESS
Advertisement
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Leerink Downgrades Eli Lilly and Company (LLY) to Market Perform From Outperform
Eli Lilly and Company (NYSE:LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded Eli Lilly and Company (NYSE:LLY) to Market Perform from Outperform with a $715 price target. The rating update came after Eli Lilly and Company (NYSE:LLY) posted its fiscal Q2 2025 earnings the same day, with revenue growing 38% to $15.56 billion, driven primarily by volume growth from Zepbound and Mounjaro. Eli Lilly and Company (NYSE:LLY) also raised the midpoint of its 2025 full-year revenue guidance by $1.5 billion, taking it to the $60 billion to $62 billion range. It also raised its reported EPS guidance to be in the $20.85 to $22.10 range. Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
a minute ago
- Yahoo
UnitedHealth's $3.3bn Amedisys deal faces strict divestiture terms
The US Justice Department's Antitrust Division has reached a settlement with health insurer UnitedHealth Group over its $3.3bn acquisition of Amedisys. UnitedHealth, which previously acquired LHC Group, a competitor to Amedisys, faced legal challenges last year when the Justice Department and state attorneys general moved to block the acquisition. Amedisys provides home health and hospice services, and is based in Baton Rouge, Louisiana. The proposed settlement stipulates that UnitedHealth must relinquish ownership of 164 home health and hospice facilities, including one palliative care centre, spread across 19 US states. These facilities collectively generate annual revenue of around $528m. Additionally, the settlement imposes a contingency that requires UnitedHealth to divest eight more locations should it encounter regulatory hurdles in the initial divestiture process. To ensure adherence to the terms, a monitoring body will be appointed to oversee the divestiture and the execution of the consent decree. The buyers of the divested assets should be equipped with the necessary resources, staff and business relationships to foster competition in areas where UnitedHealth previously had a presence. Amedisys has also been directed to pay a civil penalty of $1.1m for inaccurately certifying compliance with the Hart-Scott-Rodino Antitrust Improvements Act. The company is further mandated to conduct antitrust compliance training for its leadership to prevent future misrepresentations in its communications with the US Government. The Justice Department's Antitrust Division Assistant Attorney General, Abigail Slater, said: 'In no sector of our economy is competition more important to Americans' well-being than healthcare. This settlement protects quality and price competition for hundreds of thousands of vulnerable patients and wage competition for thousands of nurses.' Earlier this month, UnitedHealth named Wayne DeVeydt as its new CFO, replacing John Rex, who will transition to a strategic advisory role. "UnitedHealth's $3.3bn Amedisys deal faces strict divestiture terms " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
a minute ago
- Yahoo
Worthington Steel (WS) Bounced Back after Reporting Strong Results
Springview Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the same can be downloaded here. Limited partners returned +17.8% in the second quarter, bringing the year-to-date return to +15.7% compared to the S&P 500's +10.9% return in the quarter and +6.2% in the first half, including dividends. For more information on the fund's top picks in 2025, please check its top five holdings. In its second-quarter 2025 investor letter, Springview Capital Management highlighted stocks such as Worthington Steel, Inc. (NYSE:WS). Worthington Steel, Inc. (NYSE:WS) is a North America-based steel processor. The one-month return of Worthington Steel, Inc. (NYSE:WS) was -7.34%, and its shares lost 9.36% of their value over the last 52 weeks. On August 8, 2025, Worthington Steel, Inc. (NYSE:WS) stock closed at $29.94 per share, with a market capitalization of $1.523 billion. Springview Capital Management stated the following regarding Worthington Steel, Inc. (NYSE:WS) in its second quarter 2025 investor letter: "Worthington Steel, Inc. (NYSE:WS) also bounced back in Q2, following strong results for its fiscal fourth quarter (ended May). We've held our position for over a year, and while the investment has not met our expectations thus far, we continue to view it as a deeply cyclical opportunity with latent upside. A close up of a specialized steel product that is being processed in a manufacturing plant. Worthington Steel, Inc. (NYSE:WS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 13 hedge fund portfolios held Worthington Steel, Inc. (NYSE:WS) at the end of the first quarter, which was 11 in the previous quarter. While we acknowledge the potential of Worthington Steel, Inc. (NYSE:WS) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Worthington Steel, Inc. (NYSE:WS) and shared the list of successful spin-off companies and their 2025 returns. Worthington Steel, Inc. (NYSE:WS) detracted from Springview Capital Management's performance in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio